UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003507 |
|---|---|
| Receipt number | R000003967 |
| Scientific Title | Phase II trial of neoadjuvant chemotherapy with XELOX plus Bevacizumab for locally advanced rectal cancer |
| Date of disclosure of the study information | 2010/04/20 |
| Last modified on | 2018/09/27 11:22:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/19 21:27:48 | ||
| 2 | Update | 2011/10/08 19:43:50 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2012/07/15 15:23:10 | Recruitment status |
|
| 4 | Update | 2018/09/27 11:18:43 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2018/09/27 11:22:06 | Recruitment status URL releasing protocol Publication of results URL related to results and publications |
